Authors
Loading...
Randomized trial identifies a novel mutation affecting FVIII binding in von Willebrand disease, suggesting new treatment avenues.
Cacheris et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: